« Return to News | Awards & Advancement

Quintiles named a preferred provider for global PDPs

Tuesday, March 29, 2011 12:18 PM

Quintiles has been named a preferred provider to a consortium of 14 global health product development partnerships (PDPs), leveraging the combined size of their pipelines to ensure the most cost-effective use of their research and development dollars.

PDPs are not-for-profit entities that advance global health by the discovery, development and delivery of effective and affordable medicines for global neglected diseases.  The PDPs anticipate funding 128 clinical trials over the next two years. 

The members are funded, in part, by the Bill and Melinda Gates Foundation, which has committed $10 billion over the next 10 years for the poorest countries, with a portion of that funding going to the PDPs.  Funding also comes from government agencies and private entities.

Quintiles will partner with the consortium by providing one-step access to Quintiles’ global clinical development infrastructure and standards, particularly for infectious diseases such as HIV, malaria and tuberculosis.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.